Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.42 |
| ▸ | PPARG | P37231 | 7/20 | 0.42 |
| ▸ | PPARD | Q03181 | 7/20 | 0.42 |
| ▸ | PPARA | Q07869 | 7/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TLR2 | O60603 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | FABP4 | P15090 | 2/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10171416 | 0.92 | PLA2G2A (0.49) | PLA2G2ABLMGPR84PPARGPPARD | |
| SCHEMBL8198217 | 0.86 | GPR84 (0.48) | PLA2G2ABLMGPR84PPARGPPARD | |
| SCHEMBL8525433 | 0.86 | GPR84 (0.48) | PLA2G2ABLMGPR84PPARGPPARD | |
| SCHEMBL7717708 | 0.84 | BLM (0.37) | PLA2G2ABLMTSHRTDP1ALOX15 | |
| SCHEMBL3045373 | 0.80 | THRB (0.42) | TSHRALDH1A1MEN1KMT2ANAAA | |
| SCHEMBL8574590 | 0.77 | THRB (0.37) | TSHRALDH1A1MEN1KMT2ANAAA | |
| SCHEMBL10171287 | 0.76 | BLM (0.37) | PLA2G2ABLMGPR84PPARGPPARD | |
| SCHEMBL4810103 | 0.74 | DNM1 (0.37) | TSHRALDH1A1MEN1KMT2ANAAA | |
| SCHEMBL28126402 | 0.74 | DNM1 (0.42) | TSHRALDH1A1MEN1KMT2ANAAA | |
| SCHEMBL4765473 | 0.74 | TSHR (0.41) | PLA2G2ABLMGPR84TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1888491-B1 | ISOALKANE MIXTURE, ITS PREPARATION AND USE | BASF SE (DE) | 2017-03-01 | — | — | EP | disclosed |
| US-9084734-B2 | Peptide personal care compositions and methods for their use | DANISCO US INC. (US) | 2015-07-21 | — | — | US | disclosed |
| US-8962796-B2 | Modified variant Bowman Birk protease inhibitors | DANISCO US INC. (US) | 2015-02-24 | — | — | US | disclosed |
| US-8821842-B2 | Isoalkane mixture, its preparation and use | BASF SE (DE) | 2014-09-02 | — | — | US | disclosed |
| US-20130195781-A1 | Modified Variant Bowman Birk Protease Inhibitors | DANISCO US INC. (US) | 2013-08-01 | — | — | US | disclosed |
| US-8394941-B2 | Modified variant Bowman Birk Protease Inhibitors | DANISCO US INC. (US) | 2013-03-12 | — | — | US | disclosed |
| US-20120014885-A1 | Personal Care Compositions and Methods for Their Use | DANISCO US INC. | 2012-01-19 | — | — | US | disclosed |
| CN-1960699-B | Keratin binding polypeptides | BASF AG (DE) | 2011-12-28 | — | — | CN | disclosed |
| US-20110256608-A1 | Modified Variant Bowman Birk Protease Inhibitors | DANISCO US INC. (US) | 2011-10-20 | — | — | US | disclosed |
| CN-101278051-B | Personal care compositions and methods of use thereof | GENENCOR INT | 2011-10-05 | — | — | CN | disclosed |
| CN-101278051-A | Personal care compositions and methods of use thereof | GENENCOR INT (US) | 2008-10-01 | — | — | CN | disclosed |
| US-20080199420-A1 | Cosmetic oil in water emulsion ofamphiphilic polymer with hydrophilic and hydrophobic units formed from polyisobutenes modified with terminal polar groups, emulsifier, oil and water; ethylene oxide-propylene oxide block polymer modified polyisobutenyl succinic anhydride; hydroxylation, epoxidation | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-21 | — | — | US | disclosed |
| US-20080194708-A1 | Cationic Polymers as Thickeners for Aqueous and Alcoholic Compositions | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-14 | — | — | US | disclosed |
| US-20080194715-A1 | Use of Copolymers Comprising Polyisobutene in Cosmetic Compositions | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-14 | — | — | US | disclosed |
| US-20080193404-A1 | Cosmetic; free from intrinsic odors and have an extremely wide liquid interval; heat transfer liquid; fuel additives and low-temperature fuel; shock absorber oil | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-14 | — | — | US | disclosed |
| US-20080193405-A1 | Use of a Water-In-Water Emulsion Polymers in the Form of a Thickener for Cosmetic Preparations | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-14 | — | — | US | disclosed |
| CN-101193841-A | Isoalkane mixtures, their preparation and use | BASF AG (DE) | 2008-06-04 | — | — | CN | disclosed |
| US-20080075684-A1 | Keratin-Binding Polypeptides | BASF AKTIENGESELLSCHAFT (DE) | 2008-03-27 | — | — | US | disclosed |
| CN-101151016-A | Use of a water-in-water emulsion polymers in the form of a thickener for cosmetic preparations | BASF AG (DE) | 2008-03-26 | — | — | CN | disclosed |
| CN-1960699-A | Keratin binding polypeptides | BASF AG (DE) | 2007-05-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194708-A1 | Cationic Polymers as Thickeners for Aqueous and Alcoholic Compositions | ADH1A, ADH1C, PCNA | PLA2G2A 718/4885BLM 2398/4885GPR84 2082/4885 |
| US-20080199420-A1 | Cosmetic oil in water emulsion ofamphiphilic polymer with hydrophilic and hydrophobic units formed from polyisobutenes modified with terminal polar groups, emulsifier, oil and water; ethylene oxide-propylene oxide block polymer modified polyisobutenyl succinic anhydride; hydroxylation, epoxidation | HAO2, LRBA, POLB | PLA2G2A 2019/4885BLM 3588/4885GPR84 868/4885 |
| US-20080193404-A1 | Cosmetic; free from intrinsic odors and have an extremely wide liquid interval; heat transfer liquid; fuel additives and low-temperature fuel; shock absorber oil | CUTA, TRPA1, FDFT1 | PLA2G2A 2659/4885BLM 2109/4885GPR84 1214/4885 |
| US-20120014885-A1 | Personal Care Compositions and Methods for Their Use | CUTA, VEGFA, BDNF | PLA2G2A 3006/4885BLM 1878/4885GPR84 321/4885 |
| US-20130195781-A1 | Modified Variant Bowman Birk Protease Inhibitors | SERPINB1, BBC3, BRAP | PLA2G2A 2267/4885BLM 647/4885GPR84 4151/4885 |
| US-20080193405-A1 | Use of a Water-In-Water Emulsion Polymers in the Form of a Thickener for Cosmetic Preparations | POLH, POLR1C, POLQ | PLA2G2A 1534/4885BLM 1152/4885GPR84 2503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.